These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3967603)

  • 21. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma].
    Guerra P
    Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [123I-MIBG scintigraphy in patients with neuroblastoma].
    Koizumi M; Sawada H; Goto M; Iijima A; Watari T; Kurosawa H; Kurumada H; Sugita K; Furukawa T
    Kaku Igaku; 1994 May; 31(5):507-11. PubMed ID: 8028223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of neuroblastoma with 131I-meta-iodobenzylguanidine.
    Voute PA; Hoefnagel CA; Marcuse HR; de Kraker J
    Prog Clin Biol Res; 1985; 175():389-98. PubMed ID: 3991738
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of meta-iodo [131I]benzylguanidine (MIBG) in the diagnosis and follow-up of neuroblastoma.
    Miceli A; Nespoli L; Burgio GR; Aprile C; Carena M; Saponaro R
    Pediatr Hematol Oncol; 1986; 3(1):37-47. PubMed ID: 3153217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML; Bihl H; Heinze HG
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
    Hibi S; Todo S; Imashuku S; Miyazaki T
    Pediatr Radiol; 1987; 17(4):308-13. PubMed ID: 3601463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
    Shulkin BL; Shen SW; Sisson JC; Shapiro B
    J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Normal and pathological distribution of 131-m-iodobenzylguanidine in children. Contribution to the diagnosis of neuroblastoma].
    Ferris J; Caballero O; Verdaguer A; Esquembre C; Castel V
    Rev Esp Oncol; 1985; 32(3):519-28. PubMed ID: 3870542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
    Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
    Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology.
    Moyes JS; Babich JW; Carter R; Meller ST; Agrawal M; McElwain TJ
    J Nucl Med; 1989 Apr; 30(4):474-80. PubMed ID: 2738676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
    Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
    J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indications for MIBG scintigraphy in the diagnosis of neuroblastoma].
    Hausegger KA; Fueger GF; Ebner F; Urban C
    Nuklearmedizin; 1989 Feb; 28(1):34-40. PubMed ID: 2710644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
    Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D
    Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases.
    Bouvier JF; Philip T; Chauvot P; Brunat Mentigny M; Ducrettet F; Maïassi N; Lahneche BE
    Prog Clin Biol Res; 1988; 271():707-20. PubMed ID: 3261425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
    Schwarz KB; Driver I; Lewis IJ; Taylor RE
    Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of 131I-meta-iodobenzylguanidine in clinical diagnosis and staging of neuroectodermal tumors. Two case reports.
    Raes M; Coolens JL; Van de Casseye W; Casteels-Van Daele M; De Roo M
    Helv Paediatr Acta; 1986 May; 41(1-2):63-7. PubMed ID: 3721897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of 131I-meta-iodobenzylguanidine in pediatric oncology].
    Treuner J
    Nuklearmedizin; 1985 Feb; 24(1):26-8. PubMed ID: 4000978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bone marrow metastases of neuroblastoma: MRT in comparison with bone marrow cytology and mIBG scintigraphy].
    Benz-Bohm G; Gross-Fengels W; Widemann B; Linden A
    Rofo; 1990 May; 152(5):523-7. PubMed ID: 2160683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
    Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
    Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.